Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules
Condition: Tick Borne EncephalitisIntervention: Other: Blood SamplingSponsors: Novartis; Novartis VaccinesActive, not recruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials